In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L-749,345) with those of imipenem, amoxicillin-clavulanate, and ciprofloxacin against 5,558 recent clinical isolates from 11 North American medical centers. We confirmed the greater...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Fuchs, Peter C., Barry, Arthur L., Brown, Steven D.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2001
Schlagworte:	Susceptibility
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90573/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353653/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1915-1918.2001
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!